T0	Outcomes 123 144	platelet aggregation.
T1	Outcomes 267 289	cardiovascular events.
T2	Outcomes 425 446	platelet aggregation.
T3	Outcomes 756 774	Primary hemostasis
T4	Outcomes 848 955	the closure time (CT) of a collagen- and epinephrine-coated pore by aggregating platelets in flowing blood.
T5	Outcomes 978 1001	anti-aggregatory action
T6	Outcomes 1024 1027	(CT
T7	Outcomes 1171 1194	anti-aggregatory action
T8	Outcomes 1239 1241	CT
T9	Outcomes 1429 1449	platelet aggregation
T10	Outcomes 1572 1591	platelet inhibition
T11	Outcomes 1806 1825	platelet inhibition